Terms: = Thyroid cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Prognosis
44 results:
1. Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mtor pathway.
Guo M; Liu M; Li W; Wang C; Zhang L; Zhang H
J Cancer Res Clin Oncol; 2024 Mar; 150(3):155. PubMed ID: 38526702
[TBL] [Abstract] [Full Text] [Related]
2. GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mtor pathway.
Zhang W; Tang X; Peng Y; Xu Y; Liu L; Liu S
Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38334171
[TBL] [Abstract] [Full Text] [Related]
3. Characterization of the genomic alterations in poorly differentiated thyroid cancer.
Lee Y; Moon S; Seok JY; Lee JH; Nam S; Chung YS
Sci Rep; 2023 Nov; 13(1):19154. PubMed ID: 37932340
[TBL] [Abstract] [Full Text] [Related]
4. Circular RNAs: characteristics, functions, mechanisms, and potential applications in thyroid cancer.
Wu M; Yuan H; Zou W; Xu S; Liu S; Gao Q; Guo Q; Han Y; An X
Clin Transl Oncol; 2024 Apr; 26(4):808-824. PubMed ID: 37864677
[TBL] [Abstract] [Full Text] [Related]
5. NAA20 recruits Rin2 and promotes triple-negative breast cancer progression by regulating Rab5A-mediated activation of EGFR signaling.
Qiao L; Dong C; Jia W; Ma B
Cell Signal; 2023 Dec; 112():110922. PubMed ID: 37827343
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensive pan-cancer analysis of expression profiles and prognostic significance for NUMB and NUMBL in human tumors.
Zhang Y; Yang H; Liu W; Song Q; Li Y; Zhang J; Zhou D; Li A
Medicine (Baltimore); 2023 Sep; 102(35):e34717. PubMed ID: 37657045
[TBL] [Abstract] [Full Text] [Related]
7. Expression and Clinical Significance of Golgi Phosphoprotein 3 (GOLPH3) in Papillary thyroid Carcinoma.
Yu WS; Zhou ZP; Zeng JF; Huang ZQ; Qiu CZ
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):324-330. PubMed ID: 36952588
[TBL] [Abstract] [Full Text] [Related]
8. STRA6 Promotes thyroid Carcinoma Progression via Activation of the ILK/AKT/mtor Axis in Cells and Female Nude Mice.
He W; Cheng Z; Huo Z; Lin B; Wang X; Sun Y; Yu S; Cao S; Xue J; Liu R; Lv W; Li Y; Hong S; Xiao H
Endocrinology; 2023 Jan; 164(3):. PubMed ID: 36592123
[TBL] [Abstract] [Full Text] [Related]
9. Dysregulated ceRNA network modulated by copy number variation-driven lncRNAs in breast cancer: A comprehensive analysis.
Zhu X; Song J; Wang M; Wang X; Lv L
J Gene Med; 2023 Mar; 25(3):e3471. PubMed ID: 36525372
[TBL] [Abstract] [Full Text] [Related]
10. Histocompatibility Minor 13 (HM13), targeted by miR-760, exerts oncogenic role in breast cancer by suppressing autophagy and activating PI3K-AKT-mtor pathway.
Yang H; Li Z; Wang Z; Zhang X; Dai X; Zhou G; Ding Q
Cell Death Dis; 2022 Sep; 13(8):728. PubMed ID: 36153332
[TBL] [Abstract] [Full Text] [Related]
11. The Overexpression of SLC25A13 Predicts Poor prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma.
Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
[TBL] [Abstract] [Full Text] [Related]
12. ZDHHC22-mediated mtor palmitoylation restrains breast cancer growth and endocrine therapy resistance.
Huang J; Li J; Tang J; Wu Y; Dai F; Yi Z; Wang Y; Li Y; Wu Y; Ren G; Xiang T
Int J Biol Sci; 2022; 18(7):2833-2850. PubMed ID: 35541896
[TBL] [Abstract] [Full Text] [Related]
13. Ribonucleotide reductase M2 subunit silencing suppresses tumorigenesis in pancreatic cancer via inactivation of PI3K/AKT/mtor pathway.
Shan J; Wang Z; Mo Q; Long J; Fan Y; Cheng L; Zhang T; Liu X; Wang X
Pancreatology; 2022 Apr; 22(3):401-413. PubMed ID: 35300916
[TBL] [Abstract] [Full Text] [Related]
14. LEM domain containing 1 promotes pancreatic cancer growth and metastasis by p53 and mtorC1 signaling pathway.
Cao X; Yao N; Zhao Z; Fu Y; Hu Y; Zhu P; Shi W; Tang L
Bioengineered; 2022 Mar; 13(3):7771-7784. PubMed ID: 35286235
[TBL] [Abstract] [Full Text] [Related]
15. ABCA8 inhibits breast cancer cell proliferation by regulating the AMP activated protein kinase/mammalian target of rapamycin signaling pathway.
Lv C; Yang H; Yu J; Dai X
Environ Toxicol; 2022 Jun; 37(6):1423-1431. PubMed ID: 35191604
[TBL] [Abstract] [Full Text] [Related]
16. Reduced MHC class II expression in medullary thyroid cancer identifies patients with poor prognosis.
Ruan X; Yi J; Hu L; Zhi J; Zeng Y; Hou X; Huang J; Gu P; Hao W; Gao M; Pan Y; Wei S; Zheng X
Endocr Relat Cancer; 2022 Jan; 29(2):87-98. PubMed ID: 34874277
[TBL] [Abstract] [Full Text] [Related]
17. Oncogenic Mutations in PI3K/AKT/mtor Pathway Effectors Associate with Worse prognosis in
Pappa T; Ahmadi S; Marqusee E; Johnson HL; Nehs MA; Cho NL; Barletta JA; Lorch JH; Doherty GM; Lindeman NI; Alexander EK; Landa I
Clin Cancer Res; 2021 Aug; 27(15):4256-4264. PubMed ID: 34088725
[TBL] [Abstract] [Full Text] [Related]
18. Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare Associations.
Chevalier B; Dupuis H; Jannin A; Lemaitre M; Do Cao C; Cardot-Bauters C; Espiard S; Vantyghem MC
Front Endocrinol (Lausanne); 2021; 12():678869. PubMed ID: 34025587
[TBL] [Abstract] [Full Text] [Related]
19. Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN.
Zhang YQ; Liang YK; Wu Y; Chen M; Chen WL; Li RH; Zeng YZ; Huang WH; Wu JD; Zeng D; Gao WL; Chen CF; Lin HY; Yang RQ; Zhu JW; Liu WL; Bai JW; Wei M; Wei XL; Zhang GJ
Cell Death Dis; 2021 May; 12(6):502. PubMed ID: 34006834
[TBL] [Abstract] [Full Text] [Related]
20. Decreased expression of TNFRSF12A in thyroid gland cancer predicts poor prognosis: A study based on TCGA data.
Wu ZH; Niu X; Wu GH; Cheng Q
Medicine (Baltimore); 2020 Aug; 99(34):e21882. PubMed ID: 32846846
[TBL] [Abstract] [Full Text] [Related]
[Next]
